Method and System for Detection of Disease Patterns
Simple SummaryContent extracted from patent full text and abstract with AI.
This invention describes a method and system for detecting disease conditions by analyzing samples, especially body fluids, using electron spin resonance spectroscopy to measure the concentration of specific components such as ferritin and carbonate radicals. The approach allows for in-vivo spectroscopic analysis to assess biomarkers related to various diseases.
Use CasesContent extracted from patent full text and abstract with AI.
- Early detection of diseases such as iron metabolism disorders by measuring ferritin levels in blood or other body fluids
- Real-time monitoring of oxidative stress or inflammatory conditions by quantifying carbonate radicals in patients
- Non-invasive or minimally invasive diagnostics in clinical laboratories for rapid assessment of disease markers
- Use in research environments to study progression and treatment of diseases involving free radicals or abnormal ferritin levels
BenefitsContent extracted from patent full text and abstract with AI.
- Enables precise and early detection of disease markers for timely intervention
- Facilitates non-invasive or minimally invasive diagnostic procedures
- Allows for real-time, in-vivo biomarker measurement increasing diagnostic accuracy
- Can improve patient outcomes by quickly identifying abnormal physiological states
- Versatile application for various diseases due to the broad range of measurable biomarkers
Technical Classifications (CPCs)
Main Classifications
Health, Food & Consumer Tech
Physics & Measurement
Sub Classifications
Measuring & Testing
Medical & Vet Science
CPC Codes
Inventors & Applicants
Applicants
Friedrich Alexander Universität Erlangen Nürnberg
Patent Abstract
Die Erfindung bezieht sich auf ein Verfahren und ein System zur Detektion von Krankheitsbildern, bei dem eine Probe (P) mittels Elektronenspinresonanzspektroskopie hinsichtlich einer Konzentration zumindest eines vorgegebenen Bestandteils insbesondere einer Körperflüssigkeit insbesondere in-vivo spektroskopisch analysiert wird, wobei der zumindest eine vorgegebene Bestandteil insbesondere zumindest eines ist von – Ferritin, dessen Konzentration bestimmt wird, und – Karbonatradikal, insbesondere aus einer Reaktion von Peroxynitrit und Kohlenstoffdioxid entstehendem Karbonatradikal, dessen Konzentration bestimmt wird.
Key Information
Publication No.
DE102014112924A1
Family ID
55358314
Publication Date
2016-03-10
Application No.
DE102014112924A
Application Date
2014-09-09
Priority Date
2014-09-09
Granted
No
Possible Cooperation
For further information please contact the transfer office.